GL1X · GenesisL1 explorer

MolNFT v1 · #97776 · protein

Crystal structure of human phosphodiesterase 4B (PDE4B) in complex with a [1,3,5]TRIAZINE derivative

4KP6 · Camp-specific 3',5'-cyclic phosphodiesterase 4B: “Crystal structure of human phosphodiesterase 4B (PDE4B) in complex with a [1,3,5]TRIAZINE derivative”. X-ray diffraction, 3 ligands (1S1, MG, ZN), 2 pockets (best druggability 0.75).…

PDB
4KP6
Type
protein
Length
324 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp-specific 3',5'-cyclic phosphodiesterase 4B
EC
3.1.4.17
UniProt
Q07343
Ligands
1S1, MG, ZN
Pockets
2 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 66% helix, 1% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACamp-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.17)protein32466% helix, 1% strandQ07343

Ligands and binding sites

  • 1S1 · 2-ethyl-2-{[4-(methylamino)-6-(1H-1,2,4-triazol-1-yl)-1,3,5-triazin-2-yl]amino}butanenitrile · ligand · chains A
  • MG · Magnesium ion · metal · chains A
  • ZN · Zinc ion · metal · chains A
  • EDO · 1,2-ethanediol · additive · 19 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14440.750.84391S1, MG, EDO
2530.290.7513empty

Compared structures

  • 4KP6 · Crystal structure of human phosphodiesterase 4B (PDE4B) in complex with a [1,3,5]triazine… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q07343 · AlphaFold monomer V2.0 prediction for camp-specific 3',5'-cyclic phosphodiesterase 4B… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.